In this issue

The Next Shot at Covid Might Be a Pill
A Merck antiviral drug in late-stage trials could help end the pandemic.

Tennis Is a Missed Business Opportunity
A new players group wants the game to fix its broken economics.

To Build a Road
When Covid isolated a tiny Minnesota town, residents cut a path to survival..

The Golden Ticket

Companies and countries that depend on travel or large gatherings are counting on the unproven concept of vaccine passports

5 mins

The Preteen's Guide to Getting Rich Off YouTube

Ryan Kaji’s video empire makes most of its revenue from merchandise, not ads

5 mins

How to Grow Better Space Lettuce

NASA is funding research on a technique that could increase the yields of extraterrestrial crops

3 mins

This Watchdog Looks Feisty Again

Under new management, the CFPB is knocking on banks’ doors and asking questions

4 mins

Fear of a Digital Dollar

Central bankers are looking at virtual currencies that could work without banks

5 mins

Scamming The Stimulus

Attempts to filter out illicit unemployment claims are contributing to already huge backlogs

4 mins

The End Of Shame

The abject public apology, a mainstay of American politics since Grover Cleveland, is fading

4 mins

How About A Covid Pill?

Vaccines are great and all, but molnupiravir, an antiviral drug in late-stage trials, could give doctors another major tool to end the pandemic—if, of course, it proves safe and effective

10+ mins

Disorder on the Court

With Rafa, Roger, and Serena in the twilight of their careers, pro tennis is struggling to reform itself. Some players are taking matters into their own hands.

10+ mins

Dinner: The Movie

Amid the rise in instructional cooking videos, the ability to entertain still rules.

3 mins

Read all stories from Bloomberg Businessweek US

Bloomberg Businessweek US Magazine Description:

Bloomberg Businessweek delivers the business information you need: surprising and timely perspectives on the most important issues of today and unique stories you won’t find anywhere else. With Bloomberg Businessweek you'll have the insights you need to take advantage of the new reality and thrive in today's complex global economy.